Whatsa,
"A company that has never trialed cavatak with their drug in my opinion won’t be spending the cash on Viralytics.."
I think I am being dim here, but I don't quite understand.
You do know that cavatak is being trialed Bristol's yervoy (ipilimumab)? So they are that likely second bidder.
https://clinicaltrials.gov/ct2/show/NCT02307149?term=cavatak&rank=3
https://clinicaltrials.gov/ct2/show/NCT03408587?term=cavatak&rank=6
